April 1 - 5, 2017
Walter E. Washington Convention Center
Washington, D.C., USA
Abstract submission deadline: Thursday, November 17
Advance registration deadline: Sunday, January 29
Clinical Trials Abstract Submission Deadline: Thursday, January 12, 2017
The online abstract submitter is now closed.
What to Submit
View clinical trials (CT) and placeholder (PL) abstract submission categories.
Trials in Progress Abstract Submission Guidelines The Trials in Progress category provides a unique opportunity for members of the research community to present ongoing trials and discuss correlatives and novel trial designs with colleagues.
Any phase (I, II, or III) trial that is ongoing and has not yet reached prespecified endpoints for analysis may be considered for inclusion in the Trials in Progress submission category. As such, inclusion of results would be improper and is strictly forbidden.
All submissions will be reviewed for appropriateness by the AACR Annual Meeting Clinical Trials Committee. Accepted submissions will be presented in the Trials in Progress Poster Session.
Abstracts should include Background and Methods only:
What is not acceptable in a Trials in Progress abstract?
Encore Abstract Submission Guidelines The AACR Annual Meeting 2017 will be accepting encore clinical trials presentations, including trials in progress (TiP). Authors must supply information regarding the original presentation, indicating the name of the meeting and publication number at the time of submission. The first author will be responsible for obtaining, and, upon request, showing proof that written permission has been obtained from the copyright holder of the original abstract publication(s). Encore TiP abstract submissions will be accepted for poster presentation only.
Encore submissions must:
Clinical Trials (Including Combination Trials) Abstract Categories
Placeholder Abstract Categories
Top of page